HLB Pep Co., Ltd. Logo

HLB Pep Co., Ltd.

Develops and produces GMP peptides, APIs, and custom synthesis for the biopharma industry.

196300 | KO

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
South Korea
Address:
광주광역시 북구 첨단과기로 333 광주테크노파크 시험생산동 206호 , 광주광역시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

HLB Pep Co., Ltd. is a biotechnology company that develops and produces therapeutic peptides and peptide-based biomaterials. The company's core activities include the manufacture and sale of Active Pharmaceutical Ingredients (APIs) from its GMP-certified facility, which was the first of its kind in Korea dedicated to peptide production. Its product and service portfolio consists of GMP and generic peptides, custom peptide synthesis for specific client requirements, and an extensive catalog of approximately 1,000 research peptides, including hormones, neuropeptides, and neurotoxins. HLB Pep focuses on research and development to discover new drug candidates, aiming to commercialize its innovations and expand its presence as a global biopharmaceutical firm.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for HLB Pep Co., Ltd. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-09-15 00:00
Legal Proceedings Report
주요사항보고서(영업정지)
Korean 9.5 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 987.6 KB

Automate Your Workflow. Get a real-time feed of all HLB Pep Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for HLB Pep Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Pluri Inc. Logo
Develops placenta-based cell therapeutics using a proprietary 3D cell-expansion platform.
Israel PLUR
A global supplier of generic APIs using AI to accelerate drug development.
South Korea 041910
Poltreg S.A. Logo
Pioneering T-regulatory cell therapies for autoimmune diseases like diabetes, MS, and ALS.
Poland PTG
PolyPeptide Group AG Logo
A global CDMO specializing in peptide and oligonucleotide APIs for pharma and biotech partners.
Switzerland PPGN
Develops sensitive point-of-care biomarker diagnostics for human and animal health.
South Korea 335810
A global CDEMO offering end-to-end solutions for antibody therapeutics and biologics.
South Korea 334970
Develops affordable biosimilars and novel antibody drugs for life-threatening diseases.
Singapore 950210
Develops protein-based immunotherapies for metabolic diseases, immune disorders, and cancer.
South Korea 296160
PROTEINA CO.,LTD. Logo
A biotech firm specializing in proteomics for drug discovery and diagnostics in oncology.
South Korea 468530
PROTIA INC. Logo
Develops IVD kits and instruments for allergy, POCT, infectious & autoimmune diseases.
South Korea 303360

Talk to a Data Expert

Have a question? We'll get back to you promptly.